Skip to main content
. 2012 Aug 16;7(10):1598–1605. doi: 10.2215/CJN.00440112

Table 3.

Risk for infection-related hospitalizations using whole cohort

Variable Adjusted Hazard Ratio (95% CI)a
Age (by 10 yr) 0.99 (0.96–1.02)
Male sex (versus female) 1.03 (0.95–1.11)
Race
 Black 1.03 (0.85–1.26)
 White 1.00 (Reference).
 Other 0.97 (0.84–1.11)
BMI (by 1 kg/m2) 1.00 (0.96–1.03)
PD (versus HD) 1.52 (1.38–1.68)
Smoking (versus nonsmoking) 0.92 (0.83–1.03)
Nephrologist visit 6–12 mo prior (versus none) 0.91 (0.84–0.99)
Hospitalization in prior year (versus none) 1.01 (0.93–1.11)
Comorbid conditions
 Cardiovascular disease 1.03 (0.93–1.12)
 Cerebrovascular disease 0.95 (0.85–1.06)
 Chronic pulmonary disease 1.24 (1.14–1.36)
 Chronic liver disease 1.19 (0.96–1.48)
 Congestive heart failure 1.02 (0.93–1.12)
 Diabetes 1.21 (1.10–1.32)
 Hyperlipidemia 0.95 (0.88–1.04)
 Hypertension 0.99 (0.84–1.17)
 Malignancy 1.08 (0.97–1.20)
 Peripheral vascular disease 1.11 (1.02–1.22)
Laboratory data
 Albumin (by 1 g/dL) 0.94 (0.87–1.02)
 Estimated GFR (by 1 mL/min per 1.73 m2) 1.02 (1.00–1.03)
 Hemoglobin (by 1 g/dL) 0.99 (0.97–1.01)
 Phosphorus (by 1 mg/dL) 1.29 (1.04–1.59)
 Urea (by 10 mg/dL) 0.98 (0.86–1.12)

n=5858. CI, confidence interval; BMI, body mass index; PD, peritoneal dialysis; HD, hemodialysis.

a

Model adjusted for age, sex, race, BMI, dialysis modality, smoking, visit to a nephrologist 6–12 months prior, hospitalization in year prior, all comorbid conditions, and all laboratory data.